文献速递胃肠动力与功能性疾病消化内镜

胃经口内镜下肌切开术治疗难治性胃轻瘫:国际前瞻性试验结果

Gastric per-oral endoscopic myotomy (G-POEM) for refractory gastroparesis: results from an international prospective trial.
PubMed 文献 · Gut · 2021-03-19

这项国际前瞻性多中心试验纳入80例药物难治且胃排空证实受损的胃轻瘫患者,评估G-POEM的疗效与安全性。12个月临床成功率为56%(95%CI 44.8-66.7),GCSI评分中等改善,轻度操作相关不良事件5例(6%)。基线GCSI>2.6、4小时胃潴留>20%及术后1个月早期应答为临床成功的独立预测因素。

要点

  • G-POEM治疗难治性胃轻瘫12个月临床成功率为56%。
  • 基线GCSI>2.6和4小时胃潴留>20%预示临床成功。
  • 术后1个月早期应答者12个月成功几率更高。

核心结论

  • G-POEM安全性良好,但对难治性胃轻瘫的总体疗效仅为中等。
  • 不建议不加选择地使用G-POEM,需进一步研究确定最佳适应证人群。

研究设计与样本

  • 国际前瞻性多中心试验,在五个三级中心纳入80例症状性胃轻瘫且标准药物治疗无效、胃排空受损证实的患者。
  • 75例(94%)完成12个月随访。
  • 主要终点为12个月临床成功,定义为GCSI总分至少降低1分且两个分量表降低≥25%。

主要发现

  • 12个月临床成功率为56%(95%CI 44.8-66.7)。
  • GCSI评分(含分量表)在G-POEM后中等改善(p<0.05)。
  • 基线GCSI评分>2.6(OR=3.23,p=0.04)和基线4小时胃潴留>20%(OR=3.65,p=0.03)为12个月临床成功的独立预测因素。
  • 术后1个月早期应答也是12个月临床成功的独立预测因素(OR=8.75,p<0.001)。
  • 轻度操作相关不良事件发生于5例(6%)患者。

关键数值与推荐

  • 临床成功定义:12个月时GCSI总分至少降低1分且两个分量表降低≥25%。
  • 基线GCSI评分>2.6与临床成功相关(OR=3.23,p=0.04)。
  • 基线4小时胃潴留>20%与临床成功相关(OR=3.65,p=0.03)。
  • 术后1个月早期应答与临床成功相关(OR=8.75,p<0.001)。

临床怎么用

  • G-POEM可用于经选择的难治性胃轻瘫患者,但需权衡其中等疗效与安全性。
  • 基线GCSI>2.6、4小时胃潴留>20%及术后1个月早期应答者可优先考虑G-POEM。
  • 应避免不加选择地对所有难治性胃轻瘫患者使用G-POEM。

局限性

  • 未设置对照组,无法排除安慰剂效应或自然病程影响。
  • 样本量有限(80例),随访12个月。
  • 研究在五个三级中心开展,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Although gastric per-oral endoscopic myotomy (G-POEM) is considered a promising technique for the management of refractory gastroparesis, high-quality evidence is limited. We prospectively investigated the efficacy and safety of G-POEM in unselected patients with refractory gastroparesis. DESIGN: In five tertiary centres, patients with symptomatic gastroparesis refractory to standard medical therapy and confirmed by impaired gastric emptying were included. The primary endpoint was clinical success, defined as at least one score decrease in Gastroparesis Cardinal Symptom Index (GCSI) with ≥25% decrease in two subscales, at 12 months. GCSI Score and subscales, adverse events (AEs) and 36-Item Short Form questionnaire of quality of life were evaluated at baseline and 1, 3, 6 and 12 months after G-POEM. Gastric emptying study was performed before and 3 months after the procedure. RESULTS: Of 80 enrolled patients, 75 patients (94%) completed 12-month follow-up. Clinical success at 12 months was 56% (95% CI, 44.8 to 66.7). GCSI Score (including subscales) improved moderately after G-POEM (p<0.05). In a regression model, a baseline GCSI Score >2.6 (OR=3.23, p=0.04) and baseline gastric retention >20% at 4 hours (OR=3.65, p=0.03) were independent predictors of clinical success at 12 months, as was early response to G-POEM at 1 month after therapy (OR 8.75, p<0.001). Mild procedure-related AEs occurred in 5 (6%) patients. CONCLUSION: G-POEM is a safe procedure, but showed only modest overall effectiveness in the treatment of refractory gastroparesis. Further studies are required to identify the best candidates for G-POEM; unselective use of this procedure should be discouraged. TRIAL REGISTRATION NUMBER: ClinicalTrials.gov Registry NCT02732821.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Vosoughi K, Ichkhanian Y, Benias P, et al. Gastric per-oral endoscopic myotomy (G-POEM) for refractory gastroparesis: results from an international prospective trial. Gut. 2021. PMID: 33741641. doi:10.1136/gutjnl-2020-322756

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。